Compounds > nedaplatin
Page last updated: 2024-08-25

nedaplatin and Carcinoma, Anaplastic

nedaplatin has been researched along with Carcinoma, Anaplastic in 19 studies

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (5.26)18.2507
2000's4 (21.05)29.6817
2010's13 (68.42)24.3611
2020's1 (5.26)2.80

Authors

AuthorsStudies
Liang, X; Liu, Q; Yang, S; Yao, W1
Chen, M; Gu, J; Guo, W; He, X; Jiang, X; Wang, D; Wang, X; Wu, J; Xu, L; Ye, J; Yin, L; Zhang, J; Zong, D1
Fan, J; Ju, D; Li, L; Lin, C; Liu, J; Liu, Z; Nie, D; Tao, Q; Wu, J; Zhao, S1
Bian, XH; Chen, M; Gu, JJ; Guo, WJ; He, X; Jiang, XS; Qian, PD; Wang, X; Wu, J; Wu, JF; Xu, JH; Yin, L; Zhang, YW; Zhu, HF1
Chen, L; Guo, R; Li, WF; Lin, AH; Liu, X; Ma, J; Sun, Y; Zhang, F; Zhang, Y1
Cheng, ZB; Liao, H; Lin, Z; Liu, YM; Lv, BJ; Peng, PJ; Tang, C; Wang, SY; Wang, ZH1
Cheng, Z; Feng, S; Fidelis, C; Kuang, Y; Li, F; Liang, Z; Lin, Z; Ullah, S; Wang, S; Yang, Y1
Lan, XW; OuYang, PY; Su, Z; Tang, J; Xiao, Y; Xie, FY; Zou, XB1
Hou, J; Hu, Y; Li, F; Lu, Q; Wang, H; Wang, L; Xiang, W; Yu, X; Zeng, W; Zhang, Z1
Feng, B; Fu, JT; Hu, Y; Shi, D; Shi, Z1
Kobayashi, S; Mori, K; Nakagawa, K; Ohtomo, K; Okuma, K; Seto, Y; Wakui, R; Yamashita, H1
Fujiwara, K; Goto, T; Hasegawa, K; Iwasa, N; Nagao, S; Ohishi, R; Shimizu, M; Takano, M1
Karaho, T; Kogashiwa, Y; Kohno, N; Maruyama, T; Matsuda, T; Nagafuji, H; Tsubosaka, T; Yamauchi, K1
Ito, H; Kawahara, T; Kubota, Y; Makiyama, K; Oshiro, H; Sekiguchi, Z; Uemura, H1
Dai, HY; Huang, XE; Li, SY; Shi, FF; Su, XY; Tan, HY; Yin, HT1
Iwashige, M; Kikuchi, H; Kumada, K; Midorikawa, T; Nagasaki, H; Nemoto, H; Sanada, Y; Takeuchi, S; Takizawa, K; Tate, G; Yagi, H; Yoshizawa, Y1
Gamoh, M; Ishibashi, S; Ishioka, C; Kanamaru, R; Kato, S; Murakawa, Y; Shibata, H; Shimodaira, H; Shineha, R; Suzuki, T; Yoshioka, T1
Hori, G; Kamio, Y; Kitami, A; Suzuki, H; Suzuki, S; Suzuki, T; Ueshima, Y1
Adachi, S; Inoue, J; Koyama, K; Nakao, N; Ogasawara, T; Takayasu, Y; Takemura, T; Tsuji, Y; Wakimoto, E1

Trials

5 trial(s) available for nedaplatin and Carcinoma, Anaplastic

ArticleYear
Phase II trial of docetaxel combined with nedaplatin for patients with recurrent and metastatic nasopharyngeal carcinoma.
    Drug design, development and therapy, 2015, Volume: 9

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Docetaxel; Drug Design; Female; Humans; Injections, Intravenous; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Organoplatinum Compounds; Taxoids; Young Adult

2015
Phase I trial of nedaplatin chemotherapy concurrent with radiotherapy for untreated locoregionally advanced nasopharyngeal carcinoma.
    Cancer chemotherapy and pharmacology, 2016, Volume: 77, Issue:3

    Topics: Adult; Aged; Antineoplastic Agents; Carcinoma; Chemoradiotherapy; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Organoplatinum Compounds; Patient Compliance; Prospective Studies; Survival Rate

2016
Phase I study of S-1 plus nedaplatin in patients with advanced/recurrent head and neck cancer.
    Chemotherapy, 2010, Volume: 56, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Disease Progression; Drug Combinations; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Squamous Cell; Organoplatinum Compounds; Oxonic Acid; Squamous Cell Carcinoma of Head and Neck; Tegafur

2010
A new combination chemotherapy with cis-diammine-glycolatoplatinum (Nedaplatin) and 5-fluorouracil for advanced esophageal cancers.
    Internal medicine (Tokyo, Japan), 1999, Volume: 38, Issue:11

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Esophageal Neoplasms; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Metastasis; Organoplatinum Compounds; Pilot Projects; Prognosis

1999
Phase I/II study of intravenous nedaplatin and intraarterial cisplatin with transcatheter arterial embolization for patients with locally advanced uterine cervical carcinoma.
    Cancer, 2001, Jan-01, Volume: 91, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Dose-Response Relationship, Drug; Embolization, Therapeutic; Female; Humans; Hysterectomy; Infusions, Intra-Arterial; Infusions, Intravenous; Magnetic Resonance Imaging; Middle Aged; Organoplatinum Compounds; Treatment Outcome; Uterine Cervical Neoplasms

2001

Other Studies

14 other study(ies) available for nedaplatin and Carcinoma, Anaplastic

ArticleYear
Efficacy and toxicity of three concurrent chemoradiotherapy regimens in treating nasopharyngeal carcinoma: Comparison among cisplatin, nedaplatin, and lobaplatin.
    Medicine, 2022, Dec-09, Volume: 101, Issue:49

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Radiotherapy, Intensity-Modulated; Retrospective Studies; Thrombocytopenia

2022
Radiosensitization effect of nedaplatin on nasopharyngeal carcinoma cells in different status of Epstein-Barr virus infection.
    BioMed research international, 2014, Volume: 2014

    Topics: Apoptosis; Carcinoma; Cell Line, Tumor; Cell Survival; Epstein-Barr Virus Infections; G2 Phase Cell Cycle Checkpoints; Herpesvirus 4, Human; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Organoplatinum Compounds; Radiation Tolerance; Radiation-Sensitizing Agents

2014
Inhibition of Autophagy Potentiated the Antitumor Effect of Nedaplatin in Cisplatin-Resistant Nasopharyngeal Carcinoma Cells.
    PloS one, 2015, Volume: 10, Issue:8

    Topics: Adenine; Antineoplastic Agents; Apoptosis; Autophagy; Butadienes; Carcinoma; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Drug Resistance, Neoplasm; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Humans; Macrolides; Microtubule-Associated Proteins; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Nitriles; Organoplatinum Compounds; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Signal Transduction; TOR Serine-Threonine Kinases

2015
Long-Term Results of Concurrent Chemoradiotherapy for Advanced N2-3 Stage Nasopharyngeal Carcinoma.
    PloS one, 2015, Volume: 10, Issue:9

    Topics: Adult; Antineoplastic Agents; Carcinoma; Chemoradiotherapy; Female; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Organoplatinum Compounds; Prognosis; Survivors

2015
Efficacy of Concurrent Chemotherapy for Intermediate Risk NPC in the Intensity-Modulated Radiotherapy Era: a Propensity-Matched Analysis.
    Scientific reports, 2015, Nov-27, Volume: 5

    Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Carcinoma; Case-Control Studies; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Gamma Rays; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Organoplatinum Compounds; Prognosis; Risk; Survival Analysis; Taxoids; Treatment Outcome

2015
Retrospective Analysis of the Survival Benefit of Induction Chemotherapy in Stage IVa-b Nasopharyngeal Carcinoma.
    PloS one, 2016, Volume: 11, Issue:8

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Disease-Free Survival; Female; Humans; Induction Chemotherapy; Kaplan-Meier Estimate; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Organoplatinum Compounds; Radiotherapy, Intensity-Modulated; Retrospective Studies; Treatment Outcome

2016
Value of intravoxel incoherent motion and dynamic contrast-enhanced MRI for predicting the early and short-term responses to chemoradiotherapy in nasopharyngeal carcinoma.
    Medicine, 2016, Volume: 95, Issue:35

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carcinoma; Chemoradiotherapy; Contrast Media; Diffusion Magnetic Resonance Imaging; Dose Fractionation, Radiation; Female; Gadolinium DTPA; Humans; Induction Chemotherapy; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm, Residual; Organoplatinum Compounds; Paclitaxel; Perfusion; Predictive Value of Tests; ROC Curve; Time Factors; Treatment Outcome

2016
Clinical efficacy and safety of gemcitabine plus nedaplatin in the treatment of advanced nasopharyngeal carcinoma.
    Journal of cancer research and therapeutics, 2016, Volume: 12, Issue:Supplement

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Case-Control Studies; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Grading; Neoplasm Staging; Organoplatinum Compounds; Treatment Outcome

2016
A retrospective comparison of clinical outcomes and quality of life measures between definitive chemoradiation alone and radical surgery for clinical stage II-III esophageal carcinoma.
    Journal of surgical oncology, 2009, Nov-01, Volume: 100, Issue:6

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Adjuvant; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Humans; Lymph Node Excision; Male; Middle Aged; Organoplatinum Compounds; Quality of Life; Radiotherapy, Adjuvant; Retrospective Studies; Sex Factors; Survival Rate

2009
Single nedaplatin treatment as salvage chemotherapy for platinum/taxane-resistant/refractory epithelial ovarian, tubal and peritoneal cancers.
    The journal of obstetrics and gynaecology research, 2010, Volume: 36, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma; Disease-Free Survival; Drug Resistance, Neoplasm; Fallopian Tube Neoplasms; Female; Humans; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Peritoneal Neoplasms; Salvage Therapy; Treatment Outcome

2010
High-grade invasive urothelial carcinoma with focal plasmacytoid differentiation successfully treated by transurethral resection followed by chemoradiotherapy.
    International journal of urology : official journal of the Japanese Urological Association, 2011, Volume: 18, Issue:12

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemoradiotherapy, Adjuvant; Cystectomy; Deoxycytidine; Female; Gemcitabine; Humans; Organoplatinum Compounds; Urinary Bladder Neoplasms; Urothelium

2011
Intervention effects of nedaplatin and cisplatin on proliferation and apoptosis of human tumour cells in vitro.
    Asian Pacific journal of cancer prevention : APJCP, 2012, Volume: 13, Issue:9

    Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Carcinoma; Cell Proliferation; Cisplatin; Drug Synergism; Esophageal Neoplasms; Female; HeLa Cells; Humans; Inhibitory Concentration 50; Ki-67 Antigen; Organoplatinum Compounds; Ovarian Neoplasms; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger

2012
[Complete remission of esophageal undifferentiated carcinoma with nedaplatin and 5-FU chemotherapy and endoesophageal brachytherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma; Combined Modality Therapy; Drug Administration Schedule; Esophageal Neoplasms; Female; Fluorouracil; Humans; Organoplatinum Compounds; Radiotherapy Dosage; Remission Induction

2003
[Thymic carcinoma successfully treated by a combination of intra-arterial infusion chemotherapy and surgery].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2000, Volume: 38, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Organoplatinum Compounds; Thymus Neoplasms; Vincristine

2000